The origin and application of experimental autoimmune encephalomyelitis
暂无分享,去创建一个
[1] Garry P Nolan,et al. Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling , 2006, Nature Methods.
[2] Jeffrey A. Cohen,et al. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group. , 1995, Neurology.
[3] S. Nelson,et al. A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosis , 2000, Neurology.
[4] J. Matthew Mauro,et al. Long-term multiple color imaging of live cells using quantum dot bioconjugates , 2003, Nature Biotechnology.
[5] E. Kabat,et al. THE PATHOLOGY OF ACUTE DISSEMINATED ENCEPHALOMYELITIS PRODUCED EXPERIMENTALLY IN THE RHESUS MONKEY AND ITS RESEMBLANCE TO HUMAN DEMYELINATING DISEASE , 1947, Journal of neuropathology and experimental neurology.
[6] E. Einstein,et al. THE ISOLATION FROM BOVINE SPINAL CORD OF A HOMOGENEOUS PROTEIN WITH ENCEPHALITOGENIC ACTIVITY * , 1962, Journal of neurochemistry.
[7] P. Y. Paterson,et al. ACUTE DISSEMINATED ENCEPHALOMYELITIS FOLLOWING IMMUNIZATION WITH HOMOLOGOUS BRAIN EXTRACTS , 1950, The Journal of experimental medicine.
[8] I. Cohen,et al. The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis , 1981, European journal of immunology.
[9] E. Kabat,et al. THE RAPID PRODUCTION OF ACUTE DISSEMINATED ENCEPHALOMYELITIS IN RHESUS MONKEYS BY INJECTION OF HETEROLOGOUS AND HOMOLOGOUS BRAIN TISSUE WITH ADJUVANTS , 1946, The Journal of experimental medicine.
[10] R. Knobler,et al. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination , 1985, Nature.
[11] A. Ben-nun,et al. The central nervous sytem-specific myelin oligodendrocytic basic protein (MOBP) is encephalitogenic and a potential target antigen in multiple sclerosis (MS) , 2000, Journal of Neuroimmunology.
[12] H. Lassmann,et al. Synergism in the Pathogenesis of EAE Induced by an MBP‐Specific T‐Cell Line and Monoclonal Antibodies to Galactocerebroside or a Myelin Oligodendroglial Glycoprotein a , 1988 .
[13] E. Kabat,et al. Rapid Production of Acute Disseminated Encephalomyelitis in Rhesus Monkeys by Injection of Brain Tissue With Adjuvants , 1946, Science.
[14] R. Shapira,et al. THE MAJOR SITE OF GUINEA‐PIG MYELIN BASIC PROTEIN ENCEPHALITOGENIC IN LEWIS RATS 1 2 , 1977, Journal of neurochemistry.
[15] C. Pettinelli,et al. Encephalitogenic activity of guinea pig myelin basic protein in the SJL mouse. , 1982, Journal of immunology.
[16] R. Fujinami,et al. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. , 1985, Science.
[17] M. Kies. PANEL DISCUSSION ON SPECIES VARIABILITY AND MULTIPLE ANTIGENS IN EAE: SUMMARY STATEMENT , 1965, Annals of the New York Academy of Sciences.
[18] P. K. Olitsky,et al. EXPERIMENTAL DISSEMINATED ENCEPHALOMYELITIS IN WHITE MICE , 1949, The Journal of experimental medicine.
[19] G. Comi,et al. Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice. , 2003, Brain : a journal of neurology.
[20] Subramaniam Sriram,et al. Experimental allergic encephalomyelitis: A misleading model of multiple sclerosis , 2005, Annals of neurology.
[21] D. Loh,et al. Murine T-cell receptor mutants with deletions of beta-chain variable region genes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[22] A. Laufer,et al. An experimental demyelinative disease in the Syrian hamster. , 1958, British journal of experimental pathology.
[23] H. Mcdevitt,et al. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention , 1988, Cell.
[24] D. McFarlin,et al. Induction of experimental allergic encephalomyelitis in PL/J and (SJL/J x PL/J)F1 mice by myelin basic protein and its peptides: localization of a second encephalitogenic determinant. , 1983, Journal of immunology.
[25] A. Baxter,et al. On lawnmowers and lay‐down misères , 2004, Immunology.
[26] A. Moser,et al. Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. , 1987, The New England journal of medicine.
[27] A. B. Robinson,et al. Experimental Allergic Encephalomyelitis: Synthesis of Disease-Inducing Site of the Basic Protein , 1970, Science.
[28] L. Roizin,et al. PRODUCTION OF EXPERIMENTAL ENCEPHALOMYEUTIS WITH CALCIUM ACETATE COMPOUND EXTRACTED FROM BRAIN TISSUE† , 1951, Journal of neuropathology and clinical neurology.
[29] T. Rivers,et al. THE ANTIBODY RESPONSE OF RABBITS TO INJECTIONS OF EMULSIONS AND EXTRACTS OF HOMOLOGOUS BRAIN , 1934, The Journal of experimental medicine.
[30] H. Mcdevitt,et al. Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[31] E. Alvord,et al. THE ENCEPHALOMYELITIC ACTIVITY OF MYELIN ISOLATED BY ULTRACENTRIFUGATION , 1962, The Journal of experimental medicine.
[32] S. Barnum,et al. Attenuation of Experimental Autoimmune Demyelination in Complement-Deficient Mice1 , 2000, The Journal of Immunology.
[33] D. McFarlin,et al. Immune response of Lewis rats to peptide C1 (residues 68-88) of guinea pig and rat myelin basic proteins , 1977, The Journal of experimental medicine.
[34] R. Grinker,et al. HUMAN RABIES AND RABIES VACCINE ENCEPHALOMYELITIS: A CLINICOPATHOLOGIC STUDY , 1930 .
[35] R. Adams,et al. The morbid anatomy of the demyelinative diseases , 1952 .
[36] P. Chattopadhyay,et al. Seventeen-colour flow cytometry: unravelling the immune system , 2004, Nature Reviews Immunology.
[37] P. Fitzgerald-Bocarsly,et al. Receptor Cross-Linking on Human Plasmacytoid Dendritic Cells Leads to the Regulation of IFN-α Production1 , 2006, The Journal of Immunology.
[38] I. Egorov,et al. Major histocompatibility complex-linked control of the murine immune response to myelin basic protein. , 1985, Journal of immunology.
[39] T. Mak,et al. Less Mortality but More Relapses in Experimental Allergic Encephalomyelitis in CD8-/- Mice , 1992, Science.
[40] G. Stuart,et al. A FATAL NEURO-PARALYTIC ACCIDENT OF ANTIRABIES TREATMENT. , 1930 .
[41] L. Morrison. Disseminated encephalomyelitis experimentally produced by the use of homologous antigen. , 1947, Archives of neurology and psychiatry.
[42] A. Verma. Progressive Multifocal Leukoencephalopathy in a Patient Treated With Natalizumab , 2006 .
[43] S. Levine,et al. Experimental allergic encephalomyelitis in inbred and outbred mice. , 1973, Journal of immunology.
[44] R. Adams,et al. A STUDY OF THE CHEMICAL NATURE OF COMPONENTS OF BOVINE WHITE MATTER EFFECTIVE IN PRODUCING ALLERGIC ENCEPHALOMYELITIS IN THE RABBIT , 1954, The Journal of experimental medicine.
[45] B. Hall,et al. Cutting Edge: FADD Is Not Required for Antigen Receptor-Mediated NF-κB Activation1 , 2005, The Journal of Immunology.
[46] H. Weiner,et al. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. , 1987, Journal of immunology.
[47] R. C. Parker,et al. Propagation of Rabies Virus in Tissue Culture.∗ , 1945, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[48] E. Spack,et al. Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[49] B. Waksman,et al. THE USE OF SPECIFIC "LYMPHOCYTE" ANTISERA TO INHIBIT HYPERSENSITIVE REACTIONS OF THE "DELAYED" TYPE , 1961, The Journal of experimental medicine.
[50] A. Ferraro. PATHOLOGY OF DEMYELINATING DISEASES AS AN ALLERGIC REACTION OF THE BRAIN , 1944 .
[51] Bernhard Ø Palsson,et al. Automated in situ measurement of cell-specific antibody secretion and laser-mediated purification for rapid cloning of highly-secreting producers. , 2005, Biotechnology and bioengineering.
[52] H. Lassmann,et al. Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat. , 2004, Brain : a journal of neurology.
[53] Lawrence Steinman,et al. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy , 1989, Cell.
[54] D. McFarlin,et al. Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein. , 1983, Journal of immunology.
[55] G. Ward,et al. Laser scanning cytometer‐based assays for measuring host cell attachment and invasion by the human pathogen Toxoplasma gondii , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[56] Attila Tárnok,et al. Laser scanning cytometry in human brain slices , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[57] P. Lehmann,et al. MBP-PLP fusion protein-induced EAE in C57BL/6 mice , 2006, Journal of Neuroimmunology.
[58] D. Kedes,et al. KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice. , 2006, The Journal of clinical investigation.
[59] E. Check. Nerve inflammation halts trial for Alzheimer's drug , 2002, Nature.
[60] N. Letvin,et al. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. , 1995, The Journal of clinical investigation.
[61] L. Steinman,et al. The coming of age for antigen‐specific therapy of multiple sclerosis , 2006, European journal of neurology.
[62] Walter Schubert,et al. A three‐symbol code for organized proteomes based on cyclical imaging of protein locations , 2007, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[63] T. Rivers,et al. OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS , 1933, The Journal of experimental medicine.
[64] A. Meshorer,et al. Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide , 1971, European journal of immunology.
[65] G. Stuart,et al. The Neuro-Paralytic Accidents of Anti-Rabies Treatment , 1928 .
[66] M. Krantz,et al. Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II‐defined cohort of patients with progressive multiple sclerosis: results of a 24‐month double‐blind placebo‐controlled clinical trial and 5 years of follow‐up treatment , 2006, European journal of neurology.
[67] P. Y. Paterson. TRANSFER OF ALLERGIC ENCEPHALOMYELITIS IN RATS BY MEANS OF LYMPH NODE CELLS , 1960, The Journal of experimental medicine.
[68] E. Spack. Antigen-specific therapies for the treatment of multiple sclerosis: a clinical trial update. , 1997, Expert opinion on investigational drugs.
[69] D. Douek,et al. Mice lacking αβ + T cells are resistant to the induction of experimental autoimmune encephalomyelitis , 1996, Journal of Neuroimmunology.
[70] N. Moldovan,et al. Quantification and functional analysis of chemotaxis by laser scanning cytometry , 2005, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[71] D. Mitchell,et al. Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein , 1988, Journal of Neuroimmunology.
[72] R. Holmdahl,et al. Analysis of autoreactive T cells associated with murine collagen-induced arthritis using peptide-MHC multimers. , 2004, International immunology.
[73] H. Lassmann,et al. Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia , 1994, The Journal of experimental medicine.
[74] R. Shapira,et al. Biological Activity and Synthesis of an Encephalitogenic Determinant , 1971, Science.
[75] J. Freund,et al. Isoallergic encephalomyelitis and radiculitis in guinea pigs after one injection of brain and Mycobacteria in water-in-oil emulsion. , 1947, Journal of immunology.
[76] H. Lassmann,et al. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system , 1993, European journal of immunology.
[77] N. Shen,et al. Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V alpha and V beta chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different , 1989, The Journal of experimental medicine.
[78] S. C. Elgin,et al. Limited heterogeneity of the major nonhistone chromosomal proteins. , 1970, Biochemistry.
[79] A. Evans,et al. Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial , 2000, Nature Medicine.
[80] H. L. Mason,et al. Relationship of Homologous Brain Proteolipid to Allergic Encephalomyelitis in Guinea Pigs , 1953, Neurology.
[81] P. Carnegie,et al. Amino acid sequence of the encephalitogenic basic protein from human myelin. , 1971, The Biochemical journal.
[82] S. Pervaiz,et al. Simultaneous analysis of steady‐state intracellular pH and cell morphology by automated laser scanning cytometry , 2007, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[83] F. Sánchez‐Madrid,et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. , 1992, Nature.
[84] Roland Martin,et al. Copolymer-1-induced inhibition of antigen-specific T cell activation: interference with antigen presentation , 1992, Journal of Neuroimmunology.
[85] T. Rivers,et al. ENCEPHALOMYELITIS ACCOMPANIED BY MYELIN DESTRUCTION EXPERIMENTALLY PRODUCED IN MONKEYS , 1935, The Journal of experimental medicine.
[86] M. Harnett,et al. Hyporesponsiveness of murine B lymphocytes exposed to the filarial nematode secreted product ES‐62 in vivo , 2003, Immunology.
[87] J. Antel,et al. NBI‐5788, an altered MBP83‐99 peptide, induces a T‐helper 2–like immune response in multiple sclerosis patients , 2000, Annals of neurology.
[88] J. Rothbard,et al. Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[89] Rena Li,et al. Microglia and inflammatory mechanisms in the clearance of amyloid β peptide , 2002 .
[90] R. Knobler,et al. Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantrone. , 1987, Clinical immunology and immunopathology.
[91] S. Wassertheil-Smoller,et al. A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis. , 1987, The New England journal of medicine.
[92] M M LIPTON,et al. Encephalomyelitis in the Rat Following Intracutaneous Injection of Central Nervous System Tissue with Adjuvant , 1952, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[93] J. Innes,et al. Experimental "allergic" encephalitis: attempts to produce the disease in sheep and goats. , 1951, Journal of comparative pathology.
[94] I. M. Morgan. ALLERGIC ENCEPHALOMYELITIS IN MONKEYS IN RESPONSE TO INJECTION OF NORMAL MONKEY NERVOUS TISSUE , 1946, The Journal of experimental medicine.
[95] R. Gold,et al. Induction of experimental autoimmune encephalomyelitis in transgenic mice expressing ovalbumin in oligodendrocytes , 2006, European journal of immunology.
[96] H. Mcdevitt,et al. Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis [published erratum appears in J Exp Med 1988 Jul 1;168(1):455] , 1988, The Journal of experimental medicine.
[97] C. Lumsden. EXPERIMENTAL “ALLERGIC” ENCEPHALOMYELITIS II.–ON THE NATURE OF THE ENCEPHALITOGENIC AGENT , 1949 .
[98] F. Barkhof,et al. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2 , 1996, Neurology.
[99] J. W. Rose,et al. Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis , 1995, Neurology.
[100] Hans Lassmann,et al. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. , 2006, Brain : a journal of neurology.
[101] Hong Jiang,et al. Role of CD8+ T Cells in Murine Experimental Allergic Encephalomyelitis , 1992, Science.
[102] E. Heber-Katz,et al. The V-region disease hypothesis: evidence from autoimmune encephalomyelitis. , 1989, Immunology today.
[103] J. Frank,et al. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand , 2000, Nature Medicine.
[104] Lawrence Steinman,et al. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis , 1986, Nature.
[105] O. Majdic,et al. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. , 1994, Journal of immunology.
[106] R. Ferrante,et al. In healthy primates, circulating autoreactive T cells mediate autoimmune disease. , 1994, The Journal of clinical investigation.
[107] V. Lennon,et al. Immunologic properties of the main encephalitogenic peptide from the basic protein of human myelin. , 1970, Journal of immunology.
[108] Michael Sela,et al. Therapeutic vaccines in autoimmunity , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[109] J. Freund,et al. The transfer of experimental allergic encephalomyelitis in the rat by means of parabiosis. , 1953, Journal of immunology.
[110] J. Freund,et al. Sensitization to Horse Serum by Means of Adjuvants , 1942 .
[111] Lawrence Steinman,et al. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis , 2006, Annals of neurology.
[112] G. Comi,et al. Vaccination with amyloid-b peptide induces autoimmune encephalomyelitis in C 57 / BL 6 mice , 2022 .